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S U M M A R Y
Background: Leishmaniasis is a parasitic disease affecting a large number of people worldwide. In this
study we carried out the molecular characterization of cutaneous leishmaniasis (CL) in Al-Madinah Al-
Munawarah Province, Saudi Arabia, conﬁrming Leishmania major and Leishmania tropica as the prevalent
species using molecular techniques.
Methods: One hundred and ﬁve patients with suspected CL were identiﬁed from four different localities
in Al-Madinah Al-Munawarah Province and Al-Miqat Hospital, Al-Madinah, Saudi Arabia. Thirty-four of
the 105 patients were selected at random for molecular investigation.
Results: Characterization of CL species by internal transcribed spacer 1 (ITS1) PCR-restriction fragment
length polymorphism (RFLP) and kinetoplast DNA (kDNA) PCR established L. major and L. tropica as the
causative organisms. kDNA PCR had a sensitivity of 90.7%, whereas ITS1 PCR had a sensitivity of 70.1%,
thus facilitating the diagnosis and species identiﬁcation. Parasite culture alone detected 39.2% and smear
alone 55.3% of the positive samples. With the exception of kDNA PCR, all other assays were 100% speciﬁc.
Conclusions: This study provides the ﬁrst ﬁndings for the comprehensive molecular characterization of
CL in Saudi Arabia.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Leishmaniasis is a parasitic disease affecting a large number of
people in 88 countries. According to the World Health Organiza-
tion (WHO), the annual incidence is estimated at 1–1.5 million
cases of cutaneous leishmaniasis (CL) and 500 000 cases of the
visceral form. About 90% of CL cases occur in only seven countries
including Afghanistan, Algeria, Brazil, Iran, Peru, Saudi Arabia, and
Syria, whereas approximately 90% of visceral leishmaniasis (VL)
cases occur in rural and suburban areas of ﬁve countries including
Bangladesh, India, Nepal, Sudan, and Brazil. CL is a dermal
manifestation caused by various Leishmania species such as L.
major, L. tropica, L. aethiopica, L. mexicana, L. amazonensis, and L.
braziliensis.1 The clinical manifestations range from spontaneously
healing lesions to chronic and mutilating cutaneous or mucocuta-
neous ulcers, and rarely a chronic diffuse cutaneous disease.2 L.
major and L. tropica are the prevalent species in semi-arid
subtropical regions including the Middle East.3–5
CL exhibits symptoms that are very similar to those seen in
several other skin diseases. The diagnosis of CL depends on the* Corresponding author. Tel.: +966 50 876 1883; fax: +966 04 8475790.
E-mail address: hesham_elbeshbishy@hotmail.com (H.A. El-Beshbishy).
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http://dx.doi.org/10.1016/j.ijid.2012.11.015demonstration of the parasite in smears or skin biopsy specimens
by direct microscopic examination. These classic methods lack a
high sensitivity and speciﬁcity and do not provide any clues
regarding the species involved in the pathogenesis of the disease.5
PCR has been applied successfully to the detection of CL in clinical
cases.6 Several PCR assays for the combined detection and
differentiation of parasites exist, including species-speciﬁc PCR,
single-strand conformation polymorphism (SSCP) analysis, and
restriction fragment length polymorphism (RFLP) analysis.7–11
Here, we present the ﬁrst comprehensive study of the
molecular characterization of CL in Al-Madinah Al-Munawarah
Province, Saudi Arabia, conﬁrming L. major and L. tropica as the
prevalent species using molecular techniques.
2. Materials and methods
2.1. Chemicals
The chemicals used in this study were of the highest analytical
grades and were purchased from Sigma-Aldrich, USA. The PCR kit
was purchased from Qiagen, UK. A Swift Maxi PCR thermal cycler
(ESCO Technologies Inc., USA) was used in this study. Primers used
in this study were purchased from TIB Molbiol, Germany.ses. Published by Elsevier Ltd. All rights reserved.
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One hundred and ﬁve patients with suspected CL were
identiﬁed from four different localities in Al-Madinah Al-Muna-
warah Province and Al-Miqat Hospital, Al-Madinah, Saudi Arabia
between October 2010 and July 2012. Suspected CL is largely
diagnosed clinically by the appearance of diffuse inﬁltrative
erythematous nodules or ulcerated lesions, which present on an
exposed area of the body. Skin biopsies were taken under sterile
conditions from the borders of the ulcers. Thirty-four of the 105
patients were selected at random for molecular investigation.
2.3. Parasite culture
Tissue material from the borders of the ulcers was collected and
inoculated into M199 medium supplemented with 25 mmol/l 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES; pH
7.5) and 20% fetal calf serum, followed by incubation at 24 8C.
Cultures were checked microscopically for promastigotes for up to
10 days. Once the culture was positive, it was propagated in the
same medium. Parasites were harvested and washed with ice-cold
phosphate buffered saline (PBS) before DNA isolation. L. major
MHOM/TM/82/Lev and L. tropica MHOM/SU/80/K28 strains were
used as reference strains in this study.
2.4. DNA isolation
Biopsy tissue was collected directly in NET buffer (150 mmol/l
NaCl, 15 mmol/l, Tris–HCl pH 8.3, and 1 mmol/l ethylenediami-
netetraacetic acid (EDTA)) for DNA isolation. DNA from parasite
cultures and from lesion biopsy smears was isolated by overnight
lysis in NET buffer containing proteinase K (Sigma) and 1% sodium
dodecyl sulfate.9
2.5. PCR ampliﬁcation
PCR ampliﬁcation was carried out using the genus-speciﬁc
primers of kinetoplast DNA (kDNA). The set of primers, namely
forward (50-GGGGTTGGTGTAAAATAGGG-30), ﬁrst-step reverse
primer (50-TTTGAACGGGATTTCTG-30), and second-step reverse
primer (50-CAGAACGCCCCTACCCG-30), was used for a nested PCR
that was carried out in two ampliﬁcation steps, both in the same
tube.12 The PCR mix was composed of 0.2 ml Taq DNA polymerase
(5 units/ml), 5 ml 10  PCR buffer, 1.25 ml dimethyl sulfoxide
(DMSO), 4 ml of 10 mM deoxyribonucleotide triphosphates
(dNTPs; 2.5 mM each), and 2.5 ml of each primer (10 pmol/ml)
to a ﬁnal volume of 50 ml. For PCR ampliﬁcation, 1 ml of reference
strain DNA (85–90 ng) or 4 ml of culture or smear sample was used
as the DNA template. The cycling conditions were 94 8C for 30 s,
followed by 30 cycles of 94 8C for 30 s, 55 8C for 60 s, and a ﬁnal
extension cycle of 72 8C for 90 s. One microliter of a 9:1 dilution of
the ﬁrst-round product in dist. H2O was used as the template for
the second round in a total volume of 50 ml under the same
conditions as those for the ﬁrst round, except with the second-step
reverse primer.Table 1
Comparative analysis of diagnostic methods in samples obtained from patients with cu
Assay Number of samples % of samples 
Conﬁrmed-positive Conﬁrmed-negative Conﬁrmed-positive 
Culture 12 22 35.3 
Smear 17 17 50 
ITS1 PCR 21 13 61.8 
kDNA PCR 24 10 70.6 
All 26 8 76.5 
PPV, positive predictive value; NPV, negative predictive value; ITS1, internal transcribeFurther identiﬁcation of Leishmania was done using the
internal transcribed spacer 1 (ITS1). The set of forward primers
LITSR (50-CTGGATCATTTTCCGATG-30) and L5.8S (50-TGATACCACT-
TATCGCACTT-30) was used to amplify 321 bp of rDNA including
parts of the 30 end of the 18S rDNA gene, complete ITS1, and part of
the 50 end of the 5.8S rDNA gene. The PCR mix and cycling
conditions were similar to those mentioned above.
The PCR assays were performed in a DNA thermal cycler, and
the products were analyzed by electrophoresis on 1.5% agarose gel.
Ten nanograms of DNA isolated from two strains of Leishmania
were also subjected to PCR experiments as positive controls.
2.6. Restriction analysis
The nested ITS1 PCR product was subjected to RFLP analysis by
digesting the PCR-ampliﬁed product with 1 U HaeIII enzyme
(Qiagen, UK) at 37 8C for 2 h. The restriction fragments were
analyzed on 1.5% agarose gel.10
2.7. Statistical analysis
Specimens were considered conﬁrmed-positive when cultures
or stained tissue smears were positive for parasites or both PCR
assays were positive for leishmanial DNA.13 When all four assays
were negative or only one PCR was positive for parasite DNA,
specimens were considered conﬁrmed-negative. These values
were used as the ‘consensus standards’ against which each
individual diagnostic assay was compared. Sensitivity, speciﬁcity,
positive predictive values (PPVs), and negative predictive values
(NPVs) were determined.14
3. Results
3.1. Analysis of diagnostic methods
Thirty-four of 105 suspected CL cases, with an average age of
24.20  12.12 years, were randomly selected and examined by the
four diagnostic methods. Results obtained with each assay were
compared for sensitivity and speciﬁcity (Table 1). Of 34 specimens
received for analysis, 26 (76.5%) were conﬁrmed-positive and eight
(23.5%) were conﬁrmed-negative (Table 1).
3.2. Tissue smears and culture studies
As deﬁned by the consensus standards, both parasite culture
and microscopic examination of smears were speciﬁc (100%) for
the diagnosis of CL, and when analyzed together, they correctly
identiﬁed 21/25 (84%) of the conﬁrmed-positive samples, showing
that for greater efﬁcacy they should be used together. The
individual sensitivity of each assay was lower, 39.2% for culture
and 55.3% for smear examination. The NPVs of culture (15.1%) and
smear (18.2%) were low. The speciﬁcity and PPV of smears and
culture were 100%, because a positive result for either was always
considered to be a true positive. The level of agreement between
Cohen’s kappa coefﬁcient (k  standard error) and diagnosis bytaneous leishmaniasis
Sensitivity (%) Speciﬁcity (%) PPV (%) NPV (%)
Conﬁrmed-negative
64.7 39.2 100 100 15.1
50 55.3 100 100 18.2
38.2 70.1 100 100 76.5
29.4 90.7 61.8 90.7 61.8
23.5
d spacer 1; kDNA, kinetoplast DNA.
Table 3
Number of lesions on each patient






H.A. El-Beshbishy et al. / International Journal of Infectious Diseases 17 (2013) e334–e338e336culture and smear was moderate (0.61  0.11), and the levels of
agreement between culture or smear and the conﬁrmed results
(conﬁrmed-positive and conﬁrmed-negative) were slight
(0.051  0.78) and poor (0.06  0.16), respectively.
3.3. Distribution of CL among samples
It was observed that the most frequent location of the site of
infection was the face 70/197 (35.5%), followed by the arms 71/197
(36.0%) and legs 56/197 (28.4%). Positive samples were found most
frequently among face smears (80%), followed by arm (53.5%) and
leg (50%) smears (Table 2).
The number of skin lesions found on each patient varied. The
majority of patients (53.3%) developed 2–3 lesions, while 29.5%
of patients developed 4–5 lesions, 8.6% of patients developed
>10 lesions, 4.8% of patients developed one lesion, and 3.8%
developed 6–10 lesions (Table 3). It was observed that the
diameter of lesions was 1–2 mm in 60.8% of samples and 3–
5 mm in 21.6%, however 15.8% had a diameter >5 mm and 1.8%
had a diameter <1 mm (Table 4). The duration of skin lesions
prior to sampling also varied among the different age groups
(Table 5).
3.4. kDNA PCR
PCR with all the culture isolates (n = 12) gave a consistent
pattern of L. tropica (720 bp), clearly differentiated from L. major
(650 bp) (Figure 1). Standard WHO reference strains of L. major and
L. tropica were used as positive controls. The assay was extended to
DNA isolated directly from dermal lesions of patients with CL to
determine its sensitivity and speciﬁcity for clinical use. Most of the
CL cases (24/34) gave positive results, whereas the DNA from
healthy skin tissue (n = 11) were all negative. kDNA PCR had the
highest sensitivity (90.7%) of any individual assay, correctly
diagnosing 24/34 of the conﬁrmed-positive. False-positives,
positive by kDNA PCR but negative by all the remaining assays,
were observed for two samples. The PPV and NPV for this assay
were 90.7% and 61.8%, respectively (Table 1). The measure of
agreement, 0.72  0.31, indicates substantial agreement between
the conﬁrmed results and the kDNA PCR.
3.5. ITS1 PCR-RFLP
DNA from culture isolates (n = 14) were subjected to ITS1
PCR-RFLP for conﬁrmation of the Leishmania species. The PCR
used to amplify the ITS1 region gave an ampliﬁed fragment of
approximately 300–350 bp with all Leishmania species, and its
subsequent digestion with the restriction enzyme HaeIII
revealed two bands for L. tropica (57 and 200 bp) and two
bands for L. major (132 and 200 bp) (Figure 2). Standards isolates
of L. tropica and L. major (two strains of each) were used as
controls. The assay was further extended to DNA isolated from
dermal lesions; the patterns corresponding to L. tropica and L.
major were obtained in all cases, and no ampliﬁcation was
observed using DNA from healthy skin tissues (n = 11). The assay
correctly identiﬁed 21/34 of the conﬁrmed-positive specimens,Table 2
Distribution of cutaneous leishmaniasis according to smear results and the site of
infection
Location Positive Negative Total % Positive
Face 56 14 70 80
Arms 38 33 71 53.5
Legs 28 28 56 50
Total 122 75 197 61.9and the sensitivity and speciﬁcity of the assay were 70.1% and
100%, respectively, No false-positives were noted. The PPV and
NPV for the ITS1 assay were 100% and 76.5%, respectively (Table
1). Agreement between the conﬁrmed results and the ITS1 PCR
was 0.39  0.15 (moderate).
4. Discussion
The presence of multiple species of Leishmania, with over-
lapping clinical pictures, demands the development of sensitive
laboratory tests with simultaneous species identiﬁcation. In a
previous study in Madinah region we found that the sand
ﬂies harbored both L. major and L. tropica as the predominant
causative agents of leishmaniasis and not L. donovani (unpub-
lished data). The diagnosis and characterization of Leishmania
species in clinical infections are important because of similar
symptoms caused by other skin diseases with overlapping clinical
presentations.15
The molecular characterization of Leishmania species in clinical
isolates of patients with CL was carried out by ITS1 PCR-RFLP
analysis. Previous reports have identiﬁed a 0.9 to 1.2 kb non-
coding spacer region present between small subunit (SSU) and
large subunit (LSU) rRNA, lying between the genes coding for 18S
and 5.8S rRNA, which are highly repetitive variable regions, that
can be used to distinguish Leishmania species by amplifying the
ITS1 region and digesting with speciﬁc restriction enzymes such as
HaeIII.10,16 To investigate the ITS1 PCR-RFLP genotyping, the
amplicon was subjected to restricted digestion with HaeIII, which
produced two different patterns that unambiguously differentiat-
ed L. tropica from L. major. In our study, all the parasite isolates
from patients with CL in Madinah displayed similar patterns,
identical to L. tropica and L. major standard strains. Furthermore,
the assay was applied to DNA isolated directly from dermal lesions,
which conﬁrmed the presence of L. tropica and L. major in the
clinical samples examined.
Diagnostic methods such as in vitro culture and direct
microscopy require the presence of a relatively high number of
viable or morphologically intact microorganisms, but in the
chronic phase of CL, the number of viable and morphologically
intact parasites in skin lesions is very low.17 In laboratories in
endemic regions, culture is often not available and diagnosis is
based on clinical features and microscopy, which have a low
sensitivity. In this study, direct microscopy on smear biopsies
showed 55.3% sensitivity, whereas culture was 39.2% sensitive.
Similar results have been reported for the sensitivity of tissue
smears (37–60%) and culture (38–40%).5,18,19Table 4
Maximum diameter of lesions






Duration of skin lesions prior to sampling
Age group (years) Delay in time prior to clinic visit
<1 month 1–2 months 3–4 months >4 months
1–9 2 36 1 3
10–20 2 27 1 2
20+ 5 19 4 3
Total 9 82 6 8
Figure 2. Agarose (1.5%) gel for characterization of Leishmania species in clinical
isolates of patients with cutaneous leishmaniasis using nested internal transcribed
spacer 1 (ITS1) PCR and restriction enzyme (HaeIII) analysis. Restriction pattern of
reference strains: L. major and L. tropica represent ITS1 PCR products; lanes 1 and 2:
L. tropica MHOM/SU/80/K28 (200 and 57 bp); lanes 3 and 4: L. major MHOM/TM/82/
Lev (203 and 132 bp); lanes 6–9: L. major samples; lanes 10–15: L. tropica samples;
lane 5: 100 bp DNA ladder.
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and genetic characterization of Leishmania in a highly sensitive
and speciﬁc manner.13,20–23 The PCR using kDNA can be used for
the diagnosis of CL and the ITS1 PCR could also be used to facilitate
the diagnosis of CL. PCR has shown promise as a sensitive tool for
the diagnosis of various parasitic diseases, and in this report we
evaluated its potential in the diagnosis and characterization of CL
with conventional direct microscopy and culture.13 The sensitivity
of the ITS1 PCR assay was 70.1% when used directly on clinical
samples, similar to that reported in earlier studies.10,16 For further
improvement in sensitivity, we exploited kDNA PCR for the
diagnosis of CL using DNA obtained directly from clinical samples.
Minicircles have been reported as an excellent target for selective
ampliﬁcation of parasite DNA.9,24,25 This assay ampliﬁes parasite
DNA with variability in amplicon size and can detect <1 pg of DNA
or as few as 10 leishmanial parasites.25 We found this assay to be
sensitive enough for the diagnosis of leishmaniasis, and it could
discriminate species such as L. tropica and L. major. Furthermore,
kDNA PCR had the highest sensitivity (90.7%) of any individual
assay, suggesting its suitability as a tool for the detection of
Leishmania parasites directly in samples from CL lesions from an
epidemiologic and treatment standpoint. No ampliﬁcation was
observed in any of the healthy skin tissues with either ITS1 or
kDNA PCR. Other groups have reported sensitivities of 85–92% for
diagnosing CL using PCR based on kDNA.26–28
The present study was focused on diagnosis and species
identiﬁcation among patients with CL in the Madinah region of
Saudi Arabia, and it was conﬁrmed that CL infections are caused by
L. tropica and L. major. kDNA PCR was the most sensitive diagnostic
assay and was established as a valuable tool in the diagnosis of CL.
The test may be used as a new standard for the detection of
parasites in patients suspected of CL with negative microscopic
examination and/or culture results. The kDNA PCR may also help in
regular randomized prospective screening in epidemiologic
surveillance studies of CL in Saudi Arabia in the near future. The
ITS1 PCR-RFLP assay is recommended for the reliable characteri-
zation of Leishmania species. Species identiﬁcation is a vital target
in the Leishmania control strategy, in therapy, and in determining
the epidemiology and dynamics of the disease.Figure 1. Agarose (1.5%) gel of the PCR products of kinetoplast DNA (kDNA) of
Leishmania species in clinical isolates of patients with cutaneous leishmaniasis.
Lanes 2 and 3: positive controls of L. tropica (720 bp) and L. major (650 bp),
respectively; lanes 4–9: L. major (650 bp); lanes 10–14: L. tropica (720 bp); lane 1:
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